Who owns HALOZYME THERAPEUTICS?
- CUSIP Number: 40637had1
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics stock
Who bought or sold HALOZYME THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wellesley Investment Advisors | 61M | $53B | -5% | Dec 2023 |
|
| Davidson Kempner Capital Management | 50M | $43M | 0% | Dec 2023 |
|
| Lazard Asset Management | 37M | $32M | 105% | Dec 2023 |
|
| Citigroup | 21M | $18M | -3% | Dec 2023 |
|
| Aviva | 20M | $17M | -5% | Dec 2023 |
|
| Citadel Advisors | 16M | $14M | 73% | Dec 2023 |
|
| D. E. Shaw & Co | 15M | $13M | 0% | Dec 2023 |
|
| Wells Fargo & Company | 15M | $13M | 4% | Dec 2023 |
|
| Readystate Asset Management | 13M | $11M | 100% | Dec 2023 |
|
| Tenor Capital Management | 12M | $10B | 0% | Dec 2023 |
|
| Wolverine Asset Management | 9.6M | $8.3M | 1% | Dec 2023 |
|
| Victory Capital Management | 9.5M | $8.2M | -27% | Dec 2023 |
|
| Jpmorgan Chase & Co | 9.4M | $8.1M | -17% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 9.3M | $8.0M | 0% | Dec 2023 |
|
| Shenkman Capital Management | 8.0M | $7.0B | -12% | Dec 2023 |
|
| Millennium Management | 7.0M | $6.1M | -22% | Dec 2023 |
|
| Man Group | 5.5M | $4.7M | -15% | Dec 2023 |
|
| Bank of America Corporation | 4.6M | $4.0M | -8% | Dec 2023 |
|
| Calamos Advisors | 4.6M | $4.0M | 0% | Dec 2023 |
|
| SSI Investment Management | 3.1M | $2.6M | -33% | Dec 2023 |
|
| Flossbach Von Storch | 2.9M | $2.5M | 0% | Dec 2023 |
|
| Palisade Capital Management | 2.8M | $2.4M | 0% | Dec 2023 |
|
| Daiwa Securities Group | 2.5M | $2.2M | -36% | Dec 2023 |
|
| Amundi | 2.3M | $2.0M | 0% | Dec 2023 |
|
| Bnp Paribas Investment Partners | 1.7M | $1.4M | 100% | Dec 2023 |
|
| Royal Bank of Canada | 1.2M | $1.0M | 0% | Dec 2023 |
|
| La Banque Postale Asset Management SA | 1.0M | $864k | 0% | Dec 2023 |
|
| Groupama Asset Managment | 750k | $648k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 600k | $518k | 100% | Dec 2023 |
|
| Barclays | 422k | $364k | -69% | Dec 2023 |
|
| CSS | 300k | $260k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 238k | $206k | 100% | Dec 2023 |
|
| D.A. Davidson & Co. | 180k | $156k | 0% | Dec 2023 |
|
| CNH Partners | 140k | $122k | 100% | Dec 2023 |
|
| Argent Trust | 70k | $61k | 0% | Dec 2023 |
|
| Foresight Capital Management Advisors | 44k | $39k | 0% | Mar 2024 |
|
| HPM Partners | 43k | $37k | 0% | Dec 2023 |
|
| Goldstein Advisors | 24k | $2.1M | 0% | Dec 2023 |
|
| Nbc Securities | 13k | $11k | -52% | Mar 2024 |
|
| Laffer Investments | 2.2k | $1.9M | -9% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 800.00 | $691k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 43.00 | $37k | 0% | Dec 2023 |
|
Who sold out of Halozyme Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Zazove Associates | Sep 2023 | 9.1M | $7.7M |
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 2.3M | $1.9M |
| SG Americas Securities | Sep 2023 | 20k | $1.7M |
| Nomura Holdings | Sep 2023 | 5.4k | $200k |